Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University
About this trial
compare the accuracy and sensitivity of 18F FDG-PET/CT and CE-CT in detecting distant metastases in breast cancer
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with pathologically proven breast cancer
Metastatic breast cancer proved by pathology or radiological modalities.
Interval between 18F-FDG PET/CT and CE-CT from one to three weeks.
Disqualifiers
Patients with known concomitant malignancy
Patients receive systemic treatment chemotherapy or radiotherapy between 18F-FDG PET/CT and CE-CT.
Trial population
patients with metastatic breast cancer
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
97 Participants
are grouped into 1 trial groupGroup A: Breast cancer Patients
Trial outcomes
Primary outcomes
1
Comparison between 18F-FDG PET/CT and CT in detecting distant metastases.
Comparison between 18F-FDG PET/CT and CT in detecting distant metastases.
Time frame
12 monthsSecondary outcomes
1
Early staging and clinical management of breast cancer in attempt to improve survival and quality of life
Early staging and clinical management of breast cancer in attempt to improve survival and quality of life
Time frame
12 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: